ANROVSSXTC• 6 Months (Normalized)
ANRO vs SXTC (Alto Neuroscience Inc. vs China SXT Pharmaceuticals Inc.)
Showing Closing Date Range from Apr 1 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $27.5
+17.47%
Alto Neuroscience Inc.
Normalized Baseline0.00%
SXTC Performance $2.51
-98.26%
China SXT Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin ANRO LEADS
+115.73 pts
ANRO outperforming by 115.73 percentage points
ANROSXTC
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO SXTC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(121 dates)
| Date | ANRO Price | ANRO Gain (%) | SXTC Price | SXTC Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $27.50 | +17.47% | $2.51 | -98.26% | +115.73% |
| Sep 22, 2026 | $30.78 | +31.48% | $- | - | |
| Sep 21, 2026 | $30.63 | +30.84% | $2.38 | -98.35% | +129.19% |
| Sep 18, 2026 | $30.27 | +29.30% | $2.40 | -98.33% | +127.63% |
| Sep 17, 2026 | $30.98 | +32.34% | $2.44 | -98.31% | +130.65% |
| Sep 16, 2026 | $30.00 | +28.15% | $2.19 | -98.48% | +126.63% |
| Sep 15, 2026 | $30.25 | +29.22% | $2.36 | -98.36% | +127.58% |
| Sep 14, 2026 | $31.68 | +35.33% | $2.66 | -98.15% | +133.48% |
| Sep 11, 2026 | $32.00 | +36.69% | $2.56 | -98.22% | +134.91% |
| Sep 10, 2026 | $31.68 | +35.33% | $1.93 | -98.66% | +133.99% |
| Sep 09, 2026 | $34.07 | +45.54% | $2.14 | -98.51% | +144.05% |
| Sep 08, 2026 | $35.81 | +52.97% | $2.24 | -98.44% | +151.41% |
| Sep 04, 2026 | $35.55 | +51.86% | $2.23 | -98.45% | +150.31% |
| Sep 03, 2026 | $36.40 | +55.49% | $2.20 | -98.47% | +153.96% |
| Sep 02, 2026 | $36.64 | +56.51% | $2.22 | -98.46% | +154.97% |
Page 1 of 9